KLRA Award Disclosure
Nicholson Nur · SEC Form 4 · Filed Sep 9, 2026
Award
Calculated transaction value
$0
Nicholson Nur Chief Technology Officer
KLRA
Transaction date
Sep 7, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 2 days later
KLRA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 220,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-386782
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kailera Therapeutics, Inc. KLRA Current | Award | Sep 7, 2026 | $0 |